Meeting Overview - The third extraordinary general meeting of shareholders was held on December 30, 2025, at the company's meeting room in Guangzhou, Guangdong Province [2] - The meeting was convened by the board of directors and chaired by Mr. Li Xiaojun, the chairman of the company [2][3] - The voting method combined on-site and online voting, complying with the Company Law and the company's articles of association [2] Attendance - Out of 10 current directors, 9 attended the meeting, with Executive Director Mr. Cheng Hongjin absent due to official duties [3] - The company’s board secretary, Ms. Huang Xuezheng, and other senior management, as well as legal witnesses and vote counters, were present [3] Resolutions - Two ordinary resolutions were passed: 1. Approval for Guangzhou Pharmaceutical Co., Ltd. to conduct accounts receivable asset securitization [4] 2. Approval for the completion of fundraising investment projects and the permanent replenishment of working capital with surplus raised funds [4] - All resolutions received more than half of the votes from the total shares represented at the meeting [5] Legal Witnessing - The meeting was witnessed by Hong Kong Central Securities Depository Co., Ltd., lawyers, and shareholder representatives who acted as vote counters and monitors [5] - The legal opinion was provided by Beijing Zhonglun (Guangzhou) Law Firm, confirming the legality and validity of the meeting's procedures and resolutions [5]

Core Points - The company held its third extraordinary general meeting of shareholders in 2025, with no proposals rejected or modified during the meeting [2][3] - The meeting was conducted both in-person and via online voting, with a total of 117 shareholders representing 107,530,810 shares, accounting for 49.6616% of the total voting shares [9][10] Meeting Details - The meeting was convened by the board of directors and chaired by Chairman Wu Xiaolin [4] - The in-person meeting took place on December 4, 2025, at 15:00, with online voting available from 9:15 to 15:00 on the same day [5][6] - The record date for shareholding was November 27, 2025 [7] - The meeting location was at the company's conference room in Weifang City, Shandong Province [8] Attendance - A total of 117 shareholders attended, representing 107,530,810 shares [9] - Among them, 10 shareholders attended in person, representing 106,877,310 shares, while 107 shareholders participated via online voting, representing 653,500 shares [10][11] - Small and medium-sized shareholders accounted for 1,836,797 shares, or 0.8483% of the total voting shares [13] Resolutions and Voting Results - The first resolution approved was to conclude the fundraising investment projects and permanently supplement the remaining funds into working capital, with 99.7334% of votes in favor [15][17] - The second resolution involved changing the auditing firm from Yongtuo to Zhihong for the 2025 fiscal year, also receiving 99.7326% approval [19][20] Legal Opinion - The meeting was witnessed by lawyers from Beijing Deheheng Law Firm, who confirmed that the meeting's procedures and voting results complied with relevant laws and regulations [20]

Core Viewpoint - The company held its seventh board meeting on December 3, 2025, where several key proposals were approved, including changes to share repurchase purposes and the implementation of stock option and employee stock ownership plans aimed at enhancing long-term incentives and attracting talent [1][2][3]. Group 1: Share Repurchase and Incentive Plans - The board approved a proposal to change the purpose of share repurchase from maintaining company value to implementing employee stock ownership and stock option plans [2][39]. - The board also approved the "2025 Striver No. 3 Stock Option Incentive Plan (Draft)" to enhance the company's long-term incentive mechanisms and align interests among shareholders, the company, and core teams [3][15]. - The board agreed on the "2025 Striver No. 3 Employee Stock Ownership Plan (Draft)" to further attract and retain talent, ensuring a focus on the company's long-term development [14][15]. Group 2: Financial Management and Fund Utilization - The board approved the conclusion of certain fundraising projects and the permanent allocation of surplus funds to enhance liquidity, which is expected to improve operational efficiency [29][55]. - The company reported a total fundraising amount of approximately RMB 1.52 billion from a non-public offering, with net proceeds after expenses being around RMB 1.5 billion [50][51]. - The surplus funds from the concluded projects will be used for daily operations and business development, ensuring compliance with relevant regulations [55][59]. Group 3: Board and Committee Changes - The board approved the addition of employee representative director Wu Yu to the audit committee, ensuring compliance with legal requirements regarding board composition [28][48]. - The board's decisions regarding the stock option and employee stock ownership plans will be submitted for shareholder approval, reflecting a commitment to transparency and governance [5][18][31]. Group 4: Upcoming Shareholder Meeting - The company announced the third temporary shareholder meeting scheduled for December 19, 2025, to discuss and vote on the approved proposals [67][69]. - The meeting will include provisions for both in-person and online voting, ensuring broad participation from shareholders [70][72].

Meeting Information - The second extraordinary general meeting of shareholders for 2025 is scheduled for September 8, 2025, at 14:00 [1] - The meeting will be held at the company's conference room located at No. 18, Huagong Road, Huabu Town, Kaihua County, Quzhou City, Zhejiang Province [1] - Voting will be conducted through a combination of on-site and online methods using the Shanghai Stock Exchange's network voting system [1] Voting Procedures - Shareholders can vote via the Shanghai Stock Exchange network voting system from 9:15 to 15:00 on the day of the meeting [1][2] - Specific voting times include trading hours: 9:15-9:25, 9:30-11:30, and 13:00-15:00 [1] - Shareholders holding multiple accounts can exercise voting rights across all accounts, but repeated votes will be counted based on the first submission [3][4] Agenda Items - The meeting will review a proposal regarding the completion and termination of certain fundraising investment projects and the permanent allocation of surplus funds to working capital [2] - This proposal has already been approved by the company's board and supervisory committee [2] Attendance Requirements - Shareholders registered by the close of business on September 1, 2025, are eligible to attend the meeting [5] - Attendees must provide identification and, if applicable, authorization documents for representatives [5] Additional Information - The meeting will last half a day, and attendees are responsible for their own travel and accommodation expenses [5] - Contact information for inquiries includes an email address and phone number for the company [5]

Group 1 - The company held its sixth meeting of the fifth supervisory board on July 15, 2025, with all six supervisors present, confirming compliance with legal and regulatory requirements [2][3]. - The supervisory board approved a proposal for joint investment with professional investment institutions and related parties, concluding that the decision-making process adhered to regulations and did not harm the interests of the company or its shareholders [2][3]. - The supervisory board also approved the completion of several fundraising investment projects, including the pig slaughtering project and modern pig farming projects, confirming they reached the intended usable state and complied with relevant regulations [3].

Core Viewpoint - New Hope Liuhe Co., Ltd. has completed the investment projects funded by the proceeds from its non-public stock issuance in September 2020 and public convertible bond issuance in November 2021, reaching the predetermined usable status and meeting the completion conditions [1][5]. Fundraising Overview - In September 2020, the company issued 177,147,918 shares at a price of RMB 22.58 per share, raising a total of approximately RMB 3.999 billion, with a net amount of approximately RMB 3.995 billion after deducting issuance costs [1][2]. - In November 2021, the company issued RMB 815 million in convertible bonds, with a net amount of approximately RMB 813 million after deducting issuance costs [3]. Fund Management - The company has established special accounts for the proceeds from both the non-public stock issuance and the public convertible bond issuance, ensuring that all funds are stored in these accounts and are subject to a tripartite supervision agreement with the sponsoring institution and the bank [4]. Project Completion Status - All investment projects funded by the proceeds from the September 2020 stock issuance and the November 2021 convertible bond issuance have been completed and reached the predetermined usable status, with no remaining funds [5].